Nivolumab,Ipilimumab
BMS
[]
nivo/folfox continues to be a clear winner for first line metastatic gastric and gej cancer (i m guessing in her2 (-) and claudin18.2 negative diseases only moving forward) #gi23 
GI medical oncologist, Associate Prof Univ of WI, public health, proud Midwesterner, opinions mine  FCOI: https://t.co/vHScVEaG0b